World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
22855
World Ranking
19952
National Ranking
9938

Best Publications

  • Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

    Eunice L. Kwak;Yung-Jue Bang;D. Ross Camidge;Alice T. Shaw

  • Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

    D W Northfelt;B J Dezube;J A Thommes;B J Miller

  • Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

    Gerd Fätkenheuer;Anton L Pozniak;Margaret A Johnson;Andreas Plettenberg

  • Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma

    John C. Morris;Antoinette R. Tan;Thomas E. Olencki;Geoffrey I. Shapiro

  • Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus.

    Young Kwon Hong;Kimberly Foreman;Jay W. Shin;Satoshi Hirakawa

  • Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

    Simon Stewart;Helmut Jablonowski;Franc D. Goebel;Keikawus Arasteh

  • Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma

    Panagiotis A. Konstantinopoulos;Steven Waggoner;Gregory A. Vidal;Monica Mita

  • Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus Infection

    Lawrence D. Kaplan;David J. Straus;Marcia A. Testa;Jamie Von Roenn

  • Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer.

    Shaveta Vinayak;Shaveta Vinayak;Sara M. Tolaney;Lee Schwartzberg;Monica Mita

  • HIV-associated plasmablastic lymphoma: Lessons learned from 112 published cases

    Jorge Castillo;Liron Pantanowitz;Bruce J. Dezube

  • Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.

    Chiang J. Li;Lin J. Zhang;Bruce J. Dezube;Clyde S. Crumpacker

  • The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients.

    Lisa L. Decker;Premalata Shankar;Gulfaraz Khan;Richard B. Freeman

  • Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.

    Joseph A. Sparano;Jeannette Y. Lee;Lawrence D. Kaplan;Alexandra M. Levine

  • Pevonedistat (MLN4924), a First‐in‐Class NEDD8‐activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study

    Ronan T. Swords;Harry P. Erba;Daniel J. Deangelo;Dale L. Bixby

  • The rising challenge of non-AIDS-defining cancers in HIV-infected patients

    John F. Deeken;Angelique Tjen-A-Looi;Michelle A. Rudek;Catherine Okuliar

  • A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas

    David S. Hong;Razelle Kurzrock;Jeffrey G. Supko;Xiaoying He

  • AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral Therapy

    Matthew C. Cheung;Liron Pantanowitz;Bruce J. Dezube

  • Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.

    Anniina Färkkilä;Doga C. Gulhan;Julia Casado;Connor A. Jacobson

  • Epidemiology, Pathophysiology, and Treatment of Kaposi Sarcoma—Associated Herpesvirus Disease: Kaposi Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman Disease

    Ryan J. Sullivan;Liron Pantanowitz;Corey Casper;Corey Casper;Justin Stebbing

  • Imatinib-Induced Regression of AIDS-Related Kaposi's Sarcoma

    Henry B. Koon;Glenn J. Bubley;Liron Pantanowitz;David Masiello

Frequent Co-Authors

Arthur B. Pardee
Arthur B. Pardee Harvard University
Geoffrey I. Shapiro
Geoffrey I. Shapiro Harvard University
Ryan J. Sullivan
Ryan J. Sullivan Harvard University
Jeannette Y. Lee
Jeannette Y. Lee University of Arkansas for Medical Sciences
Ruth M. Ruprecht
Ruth M. Ruprecht Texas Biomedical Research Institute
Mark Bower
Mark Bower Imperial College London
Clyde S. Crumpacker
Clyde S. Crumpacker Beth Israel Deaconess Medical Center
Ursula A. Matulonis
Ursula A. Matulonis Harvard University
Ronald T. Mitsuyasu
Ronald T. Mitsuyasu University of California, Los Angeles
Dirk P. Dittmer
Dirk P. Dittmer University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn't always require the traditional MD route. Numerous online degree options offer flexible entry points into healthcare. For example, fast track medical lpn programs allow students to quickly enter nursing and gain valuable patient care experience.

Those interested in advanced practice and mental health may consider the psychiatric np programs available online, enabling nurses to specialize in psychiatric and mental health care.

If you’re drawn more to healthcare management, online bachelors in health administration degrees provide foundational skills in policy, finance, and operations—ideal for administrative roles.

For further career advancement in leadership, an MHA offers deep expertise in managing healthcare organizations. Learn about the mha degree cost and find affordable programs to maximize your investment.

Diverse online pathways can help you enter the medical field, progress your qualification, or pivot to an administrative career—often at your own pace and with manageable costs.

Best Scientists Citing Bruce J. Dezube

Trending Scientists

Recently Published Articles